Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations-Reference-Cited by-同舟云学术

Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations

Published:2017-04-26 Issue:7653 Volume:545 Page:229-233
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Merkle Florian T.,Ghosh Sulagna,Kamitaki Nolan,Mitchell Jana,Avior Yishai,Mello Curtis,Kashin Seva,Mekhoubad Shila,Ilic Dusko,Charlton Maura,Saphier Genevieve,Handsaker Robert E.,Genovese Giulio,Bar Shiran,Benvenisty Nissim,McCarroll Steven A.,Eggan Kevin

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/nature22312.pdf

Reference43 articles.

1. The International Stem Cell Initiative. ISCI. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol . 29, 1132–1144 (2011)

2. Avery, S. et al. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Rep. 1, 379–386 (2013)

3. Nguyen, H. T. et al. Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL. Mol. Hum. Reprod. 20, 168–177 (2014)

4. Unger, C., Skottman, H., Blomberg, P., Dilber, M. S. & Hovatta, O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17, R48–R53 (2008)

5. Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014)

Cited by 422 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review;Pathology - Research and Practice;2024-10

2. Investigating the differential therapeutic efficacy and mechanisms of human umbilical cord mesenchymal stem cells at various passages in osteoarthritis treatment;Tissue and Cell;2024-10

3. Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases;Brain Sciences;2024-09-05

4. Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead;Nature Reviews Endocrinology;2024-09-03

5. SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes;Stem Cell Reports;2024-09